Systems Immunity Research Institute

Publications

We regularly publish our findings in high impact journals indicative of the scope and quality of the research conducted by our scientists.

Recent publications

Choy, E. et al. 2019. IL-6: To immunity and beyond. BMJ Considerations in Medicine 2 (1), pp.19-23. (10.1136/conmed-2018-000004)
Liu, Z. et al., 2019. Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death and Disease 10 55. (10.1038/s41419-018-1287-1)
Luukkonen, P. K. et al., 2019. Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids. JCI Insight 4 (16) e127902. (10.1172/jci.insight.127902)
Madura, F. et al. 2019. TCR-induced alteration of primary MHC peptide anchor residue. European Journal of Immunology 49 (7), pp.1052-1066. (10.1002/eji.201948085)
Nobre, L. V. et al., 2019. Human cytomegalovirus interactome analysis identifies degradation hubs, domain associations and viral protein functions. eLife 8 e49894. (10.7554/eLife.49894)
Protty, M. B. 2019. Coronary artery disease and schizophrenia: the interplay of heart and mind. European Heart Journal - Quality of Care and Clinical Outcomes 5 (2), pp.90-91. (10.1093/ehjqcco/qcz005)
Shelkovnikova, T. A. et al. 2019. Antiviral immune response as a trigger of FUS proteinopathy in amyotrophic lateral sclerosis. Cell Reports 29 (13), pp.4496-4508.e4. (10.1016/j.celrep.2019.11.094)
Smolen, J. S. et al., 2019. Targeting IL-6: a review of data. BMJ Considerations in Medicine 2 (1), pp.12-18. (10.1136/conmed-2018-000003)
Takeuchi, T. et al., 2019. Considering new lessons about the use of IL-6 inhibitors in arthritis. BMJ Considerations in Medicine 2 (1), pp.7-11. (10.1136/conmed-2018-000002)
Twohig, J. P. et al. 2019. Activation of naïve CD4+ T cells re-tunes STAT1 signaling to deliver unique cytokine responses in memory CD4+ T cells. Nature Immunology 20 , pp.458-470. (10.1038/s41590-019-0350-0)
Watson, H. A. et al. 2019. L-selectin enhanced T cells improve the efficacy of cancer immunotherapy. Frontiers in Immunology 10 1321. (10.3389/fimmu.2019.01321)
Wiede, F. et al., 2019. T-cell–specific PTPN2 deficiency in NOD mice accelerates the development of type 1 diabetes and autoimmune comorbidities. Diabetes 68 (6), pp.1251-1266. (10.2337/db18-1362)
Zelek, W. M. , Taylor, P. R. and Morgan, B. P. 2019. Development and characterisation of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species. Immunology 157 (4), pp.283-295. (10.1111/imm.13083)